Cyclerion Therapeutics (CYCN) Current Leases (2019 - 2021)
Cyclerion Therapeutics (CYCN) posted quarterly Current Leases of $1.4 million for Q1 2021, down 47.53% year-over-year from $2.7 million in Q1 2020, and down 57.49% quarter-over-quarter from $3.3 million in Q4 2020.
Cyclerion Therapeutics (CYCN) Current Leases (2019 - 2021) Analysis & Trends
Cyclerion Therapeutics' Current Leases history runs 3 years deep, the most recent figure standing at $1.4 million for Q1 2021.
- In Q1 2021, Current Leases fell 47.53% year-over-year to $1.4 million; the TTM figure through Mar 2021 stood at $1.4 million (down 47.53% YoY), while the FY2020 annual figure was $3.3 million, down 3.71% from the prior year.
- Current Leases for Q1 2021 stood at $1.4 million, down from $3.3 million in the prior quarter.
- The five-year high for Current Leases was $3.4 million in Q4 2019, with the low at $866000.0 in Q2 2019.
- The 3-year median for Current Leases is $3.0 million (2020), against an average of $2.6 million.
- The sharpest annual moves came in 2020 and 2021: Current Leases soared 221.82% in 2020, then slumped 47.53% in 2021.
- Cyclerion Therapeutics' Current Leases stood at $3.4 million in 2019, then dropped by 3.71% to $3.3 million in 2020, then plunged by 57.49% to $1.4 million in 2021.
- Business Quant data shows CYCN's Current Leases at $1.4 million in Q1 2021, $3.3 million in Q4 2020, and $3.1 million in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.05 Bn | 131.20 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.99 Bn | 78.00 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 65.49 Bn | 60.31 Bn | 1.37 Bn | - |
| 4 | Moderna | 56.79 Bn | 51.65 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.14 Bn | 37.05 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.27 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 27.71 Bn | 9.32 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.35 Bn | 26.51 Bn | - | - |
| 10 | Cyclerion Therapeutics | 12.84 Mn | 9.60 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 1.40 Mn |
| Dec 31, 2020 | 3.29 Mn |
| Sep 30, 2020 | 3.13 Mn |
| Jun 30, 2020 | 2.79 Mn |
| Mar 31, 2020 | 2.67 Mn |
| Dec 31, 2019 | 3.42 Mn |
| Sep 30, 2019 | 3.25 Mn |
| Jun 30, 2019 | 866,000.00 |